AGA Family of Websites:
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
March 16, 2020

What are your biggest challenges in treating C. diff?

Find the solutions you need at AGA University.
Share on facebook
Share on twitter
Share on linkedin
Share on email
Patients on antibiotics are seven to 10 times more likely to get Clostridioides difficile infection (CDI) while on the drugs and during the month after. With the rise of CDI incidence in community and acute-care settings, patients may not initially present to a GI specialist. It’s more important than ever that clinicians learn effective methods for early intervention, treatment and recurrence prevention. Complete AGA’s program to earn up to 3.5 AMA PRA Category 1 CreditsTM and hear innovative perspectives to help you identify and overcome everyday challenges, including how to:
  • Identify early signs of mild to moderate CDI based on patient risk factors and use and misuse of antibiotic therapy.
  • Evaluate patients with CDI who may be at high risk of recurrence through appropriate assay analysis.
  • Outline evidence-based approaches, including better antimicrobial stewardship, for initial and recurrent episodes of CDI.
  • Recommend treatment strategies for the prevention of recurrent CDI.
  • Explore Series
This activity is supported by an independent educational grant from Merck & Co, Inc.  
Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.